QXO Posts Strong Q3, But Proof of Sustainable Inflection Still Needed

What happened

QXO reported Q3 2026 revenue of $4.90 billion, up 79% year-over-year, with adjusted EBITDA margin expanding to 11.4%, marking a notable operating inflection after the Beacon, Kodiak, and TopBuild integrations. The company also highlighted October daily sales growth of 5.4%, suggesting momentum continuing into Q4, while the stock at $12.60 trades below its reported book value of $14.06. However, the DeepValue master report, based on filings through early August 2026, had rated QXO a WAIT, citing lack of operating proof, high leverage at 4.3x gross debt to combined EBITDA, and negative earnings with EV/EBITDA over 42x. The new Q3 figures appear to address some of those concerns, but they come from a single quarter and may include benefits from purchase accounting, seasonality, or one-time items that need verification against the 10-Q. Moreover, the market's valuation still lacks margin of safety on present earnings, and the company's $500 million buyback authorization, while supportive, only helps if shares remain below book and if cash flow improves enough to fund it without adding leverage.

Implication

The Q3 operating results represent the first concrete evidence that the integration thesis may be working, with revenue growth and margin improvement in line with management's long-term targets. However, one quarter does not establish a trend; investors should scrutinize the upcoming 10-Q for details on organic growth, segment-level margins, and whether the improvement is driven by cost reductions or merely by seasonal strength and acquisition mix. The balance sheet remains highly leveraged, and until operating cash flow inflects meaningfully above the Q1 2026 level of $70.6 million, the equity remains vulnerable to refinancing risk or dilution. A disciplined buyback below book could provide downside support, but only if the company generates sufficient free cash flow to repurchase shares without increasing debt; otherwise the announcement is more symbolic than substantive. As a result, while the risk/reward has improved from clearly negative to cautiously watchful, it does not yet justify a BUY; the next quarterly report will be the key test of whether this inflection is durable.

Thesis delta

The new Q3 data shifts the thesis from 'unproven integration story' toward 'early evidence of operating leverage,' but it does not yet overturn the WAIT rating. The master report's core concerns—high leverage, weak cash generation, and dependence on future synergies—remain; a single quarter of improved EBITDA margin is insufficient to confirm the scale benefits. The thesis delta is therefore additive but not yet transformative: the burden of proof remains on QXO to show sequential gross-margin expansion and operating cash flow above $150 million in subsequent quarters.